Detalhe da pesquisa
1.
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.
Am J Hematol
; 99(3): 396-407, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298023
2.
A novel quantitative method for assessing the therapeutic response to Tafamidis therapy in patients with cardiac TTR amyloidosis. A preliminary report.
Hell J Nucl Med
; 25(2): 216-219, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913870
3.
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Oncologist
; 26(7): 597-609, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870594
4.
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.
Am J Hematol
; 98(9): E226-E229, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340832
5.
Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia.
Br J Haematol
; 175(1): 77-86, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378193
6.
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma.
Blood
; 121(2): 318-28, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169779
7.
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories.
Front Oncol
; 13: 1123029, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36845709
8.
MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis.
Blood Adv
; 7(21): 6395-6410, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224458
9.
Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation.
Front Oncol
; 12: 934008, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35982976
10.
Bing-Neel Syndrome: Real-Life Experience in Personalized Diagnostic Approach and Treatment.
Front Oncol
; 12: 891052, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847958
11.
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD".
Cancers (Basel)
; 14(11)2022 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681747
12.
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.
In Vivo
; 36(3): 1302-1315, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35478115
13.
Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.
Blood
; 113(3): 626-34, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981296
14.
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years.
Am J Hematol
; 86(6): 479-83, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21509798
15.
Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment.
World J Gastroenterol
; 27(35): 5932-5945, 2021 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34629810
16.
Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.
Nat Commun
; 12(1): 5450, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34521827
17.
Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study.
J Clin Med
; 10(7)2021 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916376
18.
The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cells.
Br J Haematol
; 170(1): 134-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25582069
19.
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.
Blood
; 112(12): 4683-9, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18216294
20.
Targeting NF-kappaB in Waldenstrom macroglobulinemia.
Blood
; 111(10): 5068-77, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18334673